Select Biosciences Announces the Availability of Exhibition-only Passes for Screening, ADMET & MedChem Europe
News Feb 07, 2008
Select Biosciences, a provider of focused market reports, custom consultancy, recruitment, training courses and conferences to the biomedical marketplace announces that the successful Screening, MedChem and ADMET Europe conferences and exhibition will be held in Stockholm this year, at the Stockholm International Fairs & Congress Center, on February 19-20.
The event will see over 350 people gathering to attend presentations on the latest on biomolecular screening, medicinal chemistry or ADME-toxicology advances and visit an exhibition of approximately 60 related service providers and view around 70 scientific posters.
Visitors who cannot attend the whole event and its multiple options of co-located training courses, business tutorials and workshops, can register for only one day, or exhibition access only.
All passes include lunches and refreshments, prices start from just €50.
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE